Beijing WANJIE Medical Device Co., Ltd. is a national high-tech enterprise in the field of Health Care, specializing in orthopaedics and sports medicine. Since its establishment in 2006, the company has been dedicated to research, production, sales, and foreign trade. With a commitment to innovation, WANJIE boasts an innovative R&D team, led by a group of "excellent young talents" and renowned clinical experts. The company is also a vice president unit of China Sports Medicine Innovation Alliance, symbolizing its leadership position in the industry.
WANJIE's business model revolves around independent R&D and the introduction of foreign products. It has secured partnerships with leading European and American manufacturers, establishing itself as the agent for advanced orthopaedic products in these regions. A recent milestone for the company was the Private Equity Round investment received on 25th April 2021, with Elite Capital as the investors.
The company's focus on quality and innovation is evident in its advanced manufacturing equipment, including automatic processing centers and precision injection molding machines. WANJIE's product range covers high-value consumables, orthopaedic rehabilitation, and epidemic prevention products, positioning itself as a key player in the industry.
With a strong interdisciplinary team, extensive R&D capabilities, and strategic international partnerships, WANJIE Medical Device is well-positioned to achieve its vision of becoming a pioneer in orthopedics and a leader in sports medicine. Its products already have a strong presence, covering more than 80% of the top three hospitals, reflecting the trust and recognition it has garnered within the medical community.
